247 assets in Acute Lymphoblastic Leukemia

Therapeutic assets addressing Acute Lymphoblastic Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Actinium Ac 225-Dota-Daratumumab Acute Lymphoblastic Leukemia	City of Hope Medical Center	P1	C (37)
Allodepleted T Cells Acute Lymphoblastic Leukemia	Baylor College of Medicine	P1	C (37)
arm011 Acute Lymphoblastic Leukemia	TriArm Therapeutics (Taiwan) Limited	P1	C (37)
Bleximenib Acute Lymphoblastic Leukemia	Janssen Research & Development, LLC	P1	C (37)
CD19.CAR-multiVSTs Acute Lymphoblastic Leukemia	Baylor College of Medicine	P1	C (37)
cd22 car-t Acute Lymphoblastic Leukemia	Rong Tao	P1	C (37)
Daratumumab Acute Lymphoblastic Leukemia	City of Hope Medical Center	P1	C (37)
Eagd T-Cell Infusion Acute Lymphoblastic Leukemia	University of Kansas Medical Center	P1	C (37)
fxs0683 Acute Lymphoblastic Leukemia	Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.	P1	C (37)
Gnc-038 Acute Lymphoblastic Leukemia	Sichuan Baili Pharmaceutical Co., Ltd.	P1	C (37)
Hucart19-Il18 Acute Lymphoblastic Leukemia	University of Pennsylvania	P1	C (37)
Human Cd19-Cd22 Targeted T Cells Acute Lymphoblastic Leukemia	Hrain Biotechnology Co., Ltd.	P1	C (37)
ic9-car19 t cells Acute Lymphoblastic Leukemia	UNC Lineberger Comprehensive Cancer Center	P1	C (37)
Icaspase9-Transduced T Cells Acute Lymphoblastic Leukemia	Baylor College of Medicine	P1	C (37)
Icovamenib Acute Lymphoblastic Leukemia	Biomea Fusion Inc.	P1	C (37)
imj995 single agent Acute Lymphoblastic Leukemia	Novartis Pharmaceuticals	P1	C (37)
Indium In 111-Dota-Basiliximab Acute Lymphoblastic Leukemia	City of Hope Medical Center	P1	C (37)
Indium In 111-Dota-Daratumumab Acute Lymphoblastic Leukemia	City of Hope Medical Center	P1	C (37)
Jnj-75276617 Acute Lymphoblastic Leukemia	Janssen Research & Development, LLC	P1	C (37)
lv009 Acute Lymphoblastic Leukemia	PersonGen BioTherapeutics (Suzhou) Co., Ltd.	P1	C (37)
Mrx-2843 Acute Lymphoblastic Leukemia	Meryx, Inc.	P1	C (37)
Orcagraft Acute Lymphoblastic Leukemia	Orca Biosystems, Inc.	P1	C (37)
Pace Cart19 Acute Lymphoblastic Leukemia	University of Pennsylvania	P1	C (37)
Partially Engineered T-Regulatory Cell Donor Graft Trgft-201 Acute Lymphoblastic Leukemia	City of Hope Medical Center	P1	C (37)
rs001 Acute Lymphoblastic Leukemia	Guangdong Ruishun Biotech Co., Ltd	P1	C (37)
Tslpr-Cart Acute Lymphoblastic Leukemia	National Cancer Institute (NCI)	P1	C (37)
Vactosertib Acute Lymphoblastic Leukemia	David Wald	P1	C (37)
Yttrium Y 90 Basiliximab Acute Lymphoblastic Leukemia	City of Hope Medical Center	P1	C (37)
Anti-Cd19-Car Cmv-Specific T-Lymphocytes Acute Lymphoblastic Leukemia	City of Hope Medical Center	Early P1	C (34)
Anti-Cd19 Car Nk Cells Acute Lymphoblastic Leukemia	Xuzhou Medical University	Early P1	C (34)
Humanized Cd19 Car-T Cells Acute Lymphoblastic Leukemia	Zhejiang University	Early P1	C (34)
Levocarnitine Acute Lymphoblastic Leukemia	Children's Hospital of Orange County	Early P1	C (34)
Metabolically Armed Cd19 Car-T Cells Acute Lymphoblastic Leukemia	The Children's Hospital of Zhejiang University School of Medicine	Early P1	C (34)
Murine Cd19 Car-T Cells Acute Lymphoblastic Leukemia	Zhejiang University	Early P1	C (34)
prg2302 Acute Lymphoblastic Leukemia	Tan Jie	Early P1	C (34)
Rivogenlecleucel Acute Lymphoblastic Leukemia	Fred Hutchinson Cancer Center	P1/2	C (34)
Autologous Human Peripheral Blood Lymphocytes (Primarily T-Cells, Expanded With Il-2, Cd3/Cd28 Beads) Acute Lymphoblastic Leukemia	Beijing GoBroad Hospital	N/A	D (30)
Mb-Cart20.1 Acute Lymphoblastic Leukemia	Miltenyi Biomedicine GmbH	N/A	D (30)
Mb-Cart2019.1 Acute Lymphoblastic Leukemia	Miltenyi Biomedicine GmbH	N/A	D (30)
Senl_B19 Autologous Car-T Treatment Acute Lymphoblastic Leukemia	Peking University People's Hospital	N/A	D (30)
6-(4-(1,1-Dimethylethyl)phenoxy)-3-pyridinamine Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P2	D (29)
Gecacitinib Acute Lymphoblastic Leukemia	Institute of Hematology & Blood Diseases Hospital, China	N/A	D (28)
1a46 Acute Lymphoblastic Leukemia	Chimagen Biosciences, Ltd	P1/2	NR ()
A-319 Acute Lymphoblastic Leukemia	Shanxi Bethune Hospital	N/A	NR ()
Bsb-1001 Acute Lymphoblastic Leukemia	BlueSphere Bio, Inc	P1/2	NR ()
Petiveria Alliacea Preparation Acute Lymphoblastic Leukemia	Hospital Universitario San Ignacio	P1/2	NR ()
T-Cell Antigen Presenting Cells Expressing Truncated Cd19 (T-Apc) Acute Lymphoblastic Leukemia	Seattle Children's Hospital	P1	NR ()

Showing 201 to 247 of 247 assets

PreviousPage 5 of 5Next